Introduction
Adherence to antiretroviral (ARV) medications has been of concern to healthcare providers (HCP) since the first ARV medication became available in 1986 (Volberding, 1989) . The emphasis on taking Zidovudine every 4 hours was to prolong life (Fischl et al., 1987) . Studies demonstrating that an undetectable viral load decreases HIV transmission transformed ARV adherence to a public health priority (Anglemyer, Rutherford, Egger, & Siegfried, 2011; Cohen, Shaw, McMichael, & Haynes, 2011; Vaughn, Wagner, Miyashiro, Ryan, & Scott, 2011) . The urgency with which optimal adherence must occur is amplified when governments expend resources for a ''test and treat'' approach to prevention (Cohen, Chen, et al., 2011; Montaner, 2011) .
ARV adherence has been demonstrated to be essential for optimal viral suppression (Alakija Kazeem, Fadeyl, Ogunmodede, & Desalu, 2010) . Adherence above 90% has been associated with better physical function, general health, vitality, social functioning, mental health, and higher CD4 count (Wang et al., 2009) . Researchers have shown that stressful life events (SLE) have a negative impact on medication adherence and quality of life (QOL) (Bottonari, Safren, McQuaid, Hsiao, & Roberts, 2010; Sayles, Wong, Kinsler, Martins, & Cunningham, 2009; Tosevski & Milovancevic, 2006) . Leserman, Ironson, O'Cleirigh, Fordiani, and Balbin (2008) found that ''those with three or more stressful life events in the previous six months were 2.5 to 3 times more likely to be non-adherent '' to ARV medications (p. 403) . The evidence indicates that SLEs have a significant influence on overall sense of wellbeing.
Sense of coherence (SOC) reflects ''an individual's overall wellbeing and ability to cope with stress'' (Pham, Vinck, Kinkodi, & Weinstein, 2010, p. 313) , and lower SOC and health-related QOL were associated (pB0.05 to B 0.001) in HIV-infected patients (Langius-Eklof, Lidman, & Wredling, 2009 ). SOC influences QOL but does not address the degree of self-compassion (SCS) that an individual has for him/ herself. SCS was defined by Neff (2003) as ''being kind and understanding toward oneself in instances of pain or failure rather than being harshly self-critical . . . '' (p. 223) . Subsequently, Neff, Rude, and Kirkpatrick (2007) found SCS associated with happiness (r00.57) and optimism (r00.62). Heffernan, Griffin, McNulty, and Fitzpatrick (2010) observe that the elements of SCS include common humanity, selfkindness and mindfulness.
Optimal ARV adherence is facilitated by positive relationships with the HCP (Bakken et al., 2000; Demmer, 2003; Sandelowski, Voils, Chang, & Lee, 2009; Schneider, Kaplan, Greenfield, Li, & Wilson, 2004) . Further, Johnson et al. (2006) demonstrated the importance of adherence self-efficacy as mediating the relationship between the HCP and adherence. In the current study, we investigated whether SOC, SCS, and engagement with the HCP (eHCP) mediated the effects of SLEs on ARV adherence (3 days and 30 days) and whether this differed by international site.
Social Action Theory (SAT), with its emphasis on self-protective behavior, served as the theoretical foundation for this study (Ewart, 1991; Johnson, Carrico, Chesney, & Morin, 2008; Traube, Holloway, & Smith, 2011) . SAT hypothesizes that both individual level psychological factors and external environmental factors affect individual health behavior and public health priorities including ARV adherence. Possible covariates based on the literature review included (a) age, (b) gender, (c) ethnicity, (d) education, (e) country (international data collection site), (f) work for pay, and (g) AIDS status ( Figure 1) .
Method

Research design
This study is part of a multisite cross-sectional investigation that examined the role of SCS, selfefficacy, and self-esteem for HIV-positive individuals. Participants were recruited from 14 sites in the United States (Boston; Chicago; Cleveland; Corpus Christi; Durham (NC); Harlington, (TX); Newark; New York; San Francisco (three sites); Seattle (two sites); and Wilmington (NC)), as well as one site each from Canada, China, Namibia, Puerto Rico, and Thailand. These sites included HIV clinics, community-based organizations, medical centers, social service agencies, government hospitals, and an ARV clinic. Study eligibility included 18 years or older, HIV-positive, able to provide informed consent, and site-specific language ability. There was no requirement that participants be on ARV therapy. The study was administered in English at most US sites and in Canada; Chinese in China; English, Oshiwambi, Afrikaans, or Otjiherero in Namibia; Spanish in Puerto Rico and Texas; and Thai in Thailand. People were excluded from the study if there was evidence of cognitive impairment, active psychosis, or significant confusion. Data were collected between September 2009 and January 2011 by self-administered questionnaires, with support provided by assistants as needed; computer assisted self-interview (China); or one-to-one interview (Bangkok, Newark, Namibia, and Wilmington) (Webel et al., 2012) .
Protection of human subjects
The University of California-San Francisco (UCSF) secured approval for the overall study. Approval was obtained by each site director from their Protection of
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Human Subjects Committee and included approval for data-sharing with the central data repository at UCSF. Code numbers were used to protect the confidentiality of the research participants.
Instruments
Demographic questionnaire. This instrument consists of 20 items concerning such demographic questions as age, gender, ethnicity, education, work for pay, as well as queries about CD4 count, viral load, other health conditions, as well as other illness characteristics (Wantland et al., 2008) .
Stressful life events. This 20-item instrument was modified from the List of Threatening Experiences Questionnaire (LTE-Q) (Brugha, Bebbington, Tennant, & Hurry, 1985) that queried whether events occurred (Yes/No) in the last 6 or 3 months. Holzemer (2005) revised the questionnaire, adding eight items relevant to persons with HIV/AIDS to create the 20-item Stressful Life Events Questionnaire (SLE-Q) changing the time frame to 1 month. The SLE-Q measures the experience of SLE such as serious illness, injury, death of a parent or spouse, unemployment, and stigma and scores can range from 0 to 20. The Cronbach's alpha (a measure of the internal consistency of the scale items) for this new scale (and in the current study) was 0.89.
Sense of coherence.
This 13-item scale focuses on meaningfulness (4 items), comprehensibility (5 items), and manageability (4 items) using a 7-point Likert-type scale with anchors 1 (very often) and 7 (very seldom; never). Total scores range from 13 to 91. Higher scores indicate a stronger SOC. The test-retest correlations demonstrated stability (Antonovsky, 1987 (Antonovsky, , 1993 Konttinen, Haukkala, & Uutela, 2008) . While Cronbach's alpha have ranged from 0.74 to 0.91, Cronbach's alpha for the current sample was 0.60.
Self compassion scale. This 12-item instrument, adapted from Neff's (2003) 26-item SCS, queries participants regarding their response to difficult situations using a 5-point Likert-type scale with response options of 1 0almost never, 2 0rarely, 3 0sometimes, 4 0frequently, and 5 0 almost always with scores ranging from 26 to 130. The Cronbach's alpha reliability for the original 26-item instrument was 0.92 and current Cronbach's alpha reliability is 0.72.
Engagement with the provider. The 13-scale items evaluate the relationship of the research participant with their HCP (Bakken et al., 2000) . Item responses range from 1 0always true to 4 0never with scores ranging from 13 to 52. An initial question asks the participant who their HCP is by professional discipline, i.e., doctor, nurse, nurse practitioner, and physician's assistant. Cronbach's alpha for the current study was 0.96.
Adherence. ARV medication adherence was assessed by two 1-item measures; namely, the 3-and 30-day self-report visual analog scales based on Walsh et al.'s (2002) 30-day adherence assessment. Participants indicate on a scale from 0% to 100% ''For the past 3 days (30 days), what percent of the time were you able to take your medications exactly as prescribed?'' The construct validity of the 3-day visual analog scale was supported in a study by Rivet et al. (2006) .
Data analysis
Statistical tests included (a) descriptive statistics, (b) multivariate analysis of variance (MANOVA) in which several independent variables and dependent variables are examined for the significance of group differences, analysis of variance (ANOVA) with Bonferroni post-hoc analysis in which several independent variables are related to one dependent variable to examine the significance of differences, and (c) path analysis, which examined the magnitude and significance of the hypothesized relationships (Myers, Gamst, & Guarino, 2006) . All tests were conducted using SPSS 19 and Amos19 statistical packages.
Results
The sample (N 02082) was composed primarily of men (68.3%; n 01404) and was largely African American/black (41.2%, n0849), white (21.4%, n0441), or Hispanic (20.2%, n0415). The mean age for the sample was 44.9 years (SD09.4). The sample was relatively equally divided by education although only 25% (n 0515) worked for pay. Statistically significant differences by site included age, work for pay, and whether participants were informed of their AIDS status ( Table 2) ).
A one-way MANOVA was performed on six dependent variables: (a) SLEs, (b) SOC, (c) SCS, (d) eHCP, and (e) antiretroviral adherence past 3 days and past 30 days. The independent variable was international site at five levels: (a) US, (b) Canada, (c) Puerto Rico, (d) Namibia, and (e) China, was employed to determine whether the sites differed with respect to the dependent variables. The results of the MANOVA indicated a significant effect, F(28,5932) 010.91, pB0.001, partial h 2 00.044, warranting further investigation as to the relationships of the independent variables by site.
For the structural equation where adherence (past 3 days) was regressed on SOC, SCS, and eHCP to investigate the individual relationships between these variables, Canada demonstrated significant paths between SOC (b 00.20), eHCP (b 0 (0.23), and adherence (past 3 days). Namibia and Puerto Rico demonstrated a significant path only between eHCP (b 0 (0.26; b 0 (0.34), and adherence (3 days). No other international site demonstrated significant paths for the first structural equation. Other relationships between variables included a significant path between SLE and SOC with b 00.21 and b 0 (0.38 for Namibia and China, respectively, and a significant path (b 0 0.25) between SLE and eHCP for Puerto Rico. There were no significant structural paths between these variables for the United States, and the data were not available for Thailand ( Figures 2Á4) .
For the relationships for adherence (30 days) with the independent variables for each individual site, Canada and Puerto Rico demonstrated significant paths between eHCP and adherence (30 days) with paths of b 0 (0.30 and b 0 (0.22, respectively. China demonstrated a significant path (b 0 0.20) between SCS and adherence (30 days); China and Namibia reported significant paths between SLE and SOC with coefficients of b 0 (0.38 and b 00.21, respectively ( Figures 4Á6) .
To investigate the combined impact of the independent variables on adherence by international site, an examination of the relationships between SLE, SCS, SOC, and eHCP with adherence (3 days and 30 days) by international site indicated that these combined variables were related to adherence whether 3 days or 30 days to different degrees at the various sites. The combination of SLE, SCS, SOC, and eHCP was a significant predictor of adherence past 3 days for the United States (p 0 B 0.001), Canada (p 00.006), and Namibia (p 00.019). The combined independent variables AIDS Care 367 were significant predictors of adherence past 30 days only in the United States and Canada (Table 3) . Further analyses for the international sites where significant results occurred indicated that, for the United States whether for 3-or 30-day adherence, all of the independent variables contributed to an explanation of the variance. For Namibia, 11% of the 12% explained variance was due to the relationship of eHCP with adherence 3 days. In Canada, eHCP contributed almost half (6.7% of 14%) of the explained variance for 30-day adherence but less for 3-day adherence (3.6% of 17%). These finding underscore the importance of eHCP for explaining adherence whether 3 days or 30 days (Table 4 ).
Discussion
We found statistically significant (p B 0.001) sociodemographic differences by international site including age, gender, ethnicity, education, work for pay, and AIDS diagnosis. Whether one works for pay is a reflection of the country's economic situation, availability of jobs, and individual's health and support. Similarly, whether one responds they have been informed they have AIDS reflects memory, whether HCPs reveal such information, and the participant's illness stage. It is interesting that the Thai participants were both more likely to have been diagnosed with AIDS and to be employed. The Chinese sample was just a little more likely than not (56.1%) to work for pay but most had not been informed they have AIDS (86%). Whether these findings reflect differences in study participants or larger cultural differences is not clear.
ARV adherence is influenced by numerous factors but eHCP is primary with even stronger relationships with 30-day adherence. Simoni et al. (2004) suggest that longer recall periods are more likely to be correlated with viral load. The exceptions to the strength of the longer recall period are Puerto Rico and Namibia where declines in the relationship were experienced. Given that Namibia does not educate its own physicians and pharmacists and is experiencing rapid nurse turnover, the opportunity for long-term HCP relationships may be affected (UNGASS, 2010) . The lack of a full-time senior professional nurse or doctor was a significant risk factor for retention on ARVs in South Africa (Vella et al., 2010) . These results emphasize the importance of both HCP availability and quality of the patient-provider relationship (Aragones, Sanchez, Campos, & Perez, 2011; Kagee, 2008) . 
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Our Canadian data underscore the importance of addressing adherence as a public health challenge that requires intersectoral collaboration to optimize the outcomes of large-scale ARV therapy interventions such as those in British Columbia and being planned in China (British Columbia Centre for Excellence in HIV/AIDS, 2011; Montaner et al., 2010) . Financial difficulties in paying for care reflect both site differences in availability of free care and individual differences in affording required care. Boyer et al. (2011) identified financial difficulties as significant for treatment interruption.
The variables investigated in this study were of varying salience for the international sites. Much of the variance for ARV adherence remained unexplained attesting to the multinatured aspect to achieving adherence. That none of the independent variables contributed to the explained variance for Canada, which had the highest overall explained variance (17%), reflects issues of shared variance and the complexity of ARV adherence. Further, the environmental/contextual factors (SLE) and regulatory factors, (SOC, SCS, and eHCP) with outcome AIDS Care 373 (ARV adherence) varied among the study's international sites. The significance of eHCP for adherence was highlighted as it was by Watt et al. (2010) who emphasized the importance of the quality of that interaction.
This study's limitations include the unequal representation of participants with most of the sample from the United States; self-selected participation; cross-sectional design precluding investigation of changes over time; and the question of the transferability of concepts to different international sites as potentially illustrated by the of 0.60 Cronbach's alpha reliability for SOC, lower than that found in other studies (Eriksson & Lindstrom, 2006) . In addition, the self-reported adherence measure may be subject both to recall bias and social desirability bias and may have resulted in over-estimates of adherence (Grossberg, Zhang, & Gross, 2004) . Nevertheless, self-report is noted to be the least burdensome and least costly measure (Simoni et al., 2004) .
We have accommodated for unequal sample size by comparing within country differences. Nevertheless, the disadvantage of too large a sample is that analyses may result in statistical significance but not practical significance and limited power to detect differences between those sites with a small sample compared with composite US sites. Differences in the criteria used for prescription of ARV therapy (CD4 B 350/mm 3 for all sites other than Thailand, CD4 count of B200/mm 3 ) likely did not affect the results given the Thai site did not collect data on all of the study instruments and thus was not included in many analyses.
Given the significance of eHCP for ARV adherence, further investigation as to factors that enhance or impede the development of positive relationships, including the impact of relationship continuity, would be helpful. In addition, identifying variables with greater salience in different countries will help researchers isolate factors key to understanding outcomes of concern such as the different types of adherence, i.e., ARV, appointment, or condom use.
Conclusions
The relationship between SLEs and adherence is mediated through complex associations among cultural context (site) and degree of SCS, SOC, and eHCP. And, while these complex relationships differ by international site, eHCP consistently demonstrated statistical significance for ARV adherence in most of these countries. Another study contribution is to underscore that similarity of relationships for variables of interest cannot be assumed for different countries.
The importance of regular and positive eHCP cannot be overstated. Of all of this study's independent variables, eHCP made the largest contribution to both 3-and 30-day adherences. As Remien et al. (2006) note, social support makes an important contribution to adherence. The items in the eHCP scale query the degree to which the provider listens to the patient, spends enough time with the patient, and incorporates the patient in decision-making, as well as other indicators of caring and attention. This suggests that it is not so much what the HCP says but the degree to which the patient feels he or she is heard. The challenge is to make such engagement as high a priority as checking viral load, CD4 count, and the number of pills remaining in the bottle, if the patient is to remain adherent. 
